Dave Bench recently joined New York Blood Center Enterprises as Senior Vice President and Chief Financial Officer (CFO). He previously served as the Senior Vice President, CFO, Treasurer, and Corporate Secretary for Enzo Biochem, Inc., a NYSE publicly listed company, where he successfully led the convergence of clinical laboratories, life sciences, and intellectual property through the development of unique diagnostic platform technologies. David was instrumental in achieving the highest level of revenue growth in the company's 40+ year history while at the same time spearheading more than $15 million in annualized cost savings initiatives. Prior to his work at Enzo, he was the CFO at ELLKAY, LLC., a nationwide leader in healthcare connectivity. He also served as President of DBC Group, LLC., an international transaction advisory and consulting firm. Earlier in his career, David worked at the investment banking firms of Lazard and Arnhold & S. Bleichroeder. He received his B.A. in Economics and a Master's in International Economics and Finance from Brandeis University.